In order to understand the effects of azithromycin and hydroxychloroquine on the SARS-CoV-2, further pharmacokinetics analysis needs to be completed to characterize the effects of different dosages of each drug on the entire delivery pathway of the drug combination. This study assumes that both the azithromycin and the hydroxychloroquine are in equal concentrations and are not acting on another when binding to the complex; further analysis adjusted for each drug's dosage would provide better understanding of the counterbalance that each provides. More specifically, an analysis of the entire onset of pharmacokinetics at every stage of the onset, as characterized by Siddiqi et al . , would provide greater insight into, more specifically, the impact of the small molecules at each stage of the process.